Peer review reports
From: The impact of inclusion, dose and duration of pyrazinamide (PZA) on efficacy and safety outcomes in tuberculosis: systematic review and meta-analysis protocol
Original Submission |
24 Aug 2019 |
Submitted |
Original manuscript
|
4 Nov 2019 |
Author responded |
Author comments - James Millard
|
Resubmission - Version 2 |
4 Nov 2019 |
Submitted |
Manuscript version 2
|
Publishing |
12 Nov 2019 |
Editorially accepted |
|
17 Dec 2019 |
Article published |
10.1186/s13643-019-1231-1
|
Learn about peer review